Investigations on cytokines in serum of patients with Peyronie's disease;Zytokinuntersuchungen im seum von patienten mit induratio penis plastica

Aktuelle Urologie

Volumn 32, Issue SUPPL. 1, 2001, Pages 33-36

  Feil, G ^a   Bichler, K H ^a   Lahme, S ^a   Gotz T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acute phase proteins; Cytokines; Fibrosis; Induratio penis plastica; Peyronie's disease

Indexed keywords

EID: 0035597623     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15961     Document Type: Article

References (23)

1. th edition. Philadelphia: WB Saunders Company, 1992: 3011-3022
2. Gelbard MK. Dystrophic penile calcification in Peyronie's disease. J Urol 1988; 139: 738-740
3. Smith BH. Peyronie's disease. Am J Clin Pathol 1966; 45: 670-678
4. Devine Jr CJ, Somers KD, Jordan SH, Schlossberg SM. Proposal: trauma as the cause of the Peyronie's lesion. J Urol 1997; 157: 285-290
5. Leffel MS. Is there an immunogenetic basis for Peyronie's disease. J Urol 1997; 157: 295-297
6. Schiavino D, Sasso F, Nucera E, Alcini E, Gulino G, Milani A, Patriarca G. Immunologic findings in Peyronie's disease: a controlled study. Urology 1997; 50: 764-768
7. Bichler KH, Lahme S, Feil G, Götz T, Kö'mpf J, Tomiuk J. Investigations on the metabolism of collagen tissue in patients suffering from Peyronie's disease. J Urol 1999; 161: 204 (abstract)
8. Bichler KH, Lahme S, Mattauch W, Petri E. Untersuchungen zum Kollagenstoffwechsel bei Induratio penis plastica (IPP). Urologe (A) 1998; 37: 306-311
9. Somers KD, Sismour EN, Wright Jr GL, Devine Jr CJ, Gilbert DA, Horton CE. Isolation and characterization of collagen in Peyronie's disease. J Urol 1989; 141: 629-631
10. Smith BH. Peyronie's disease. Am J Clin Pathol 1969; 52: 385-390
11. Thomas L. Labor und Diagnose. Marburg: Die Medizinische Verlagsgesellschaft, 1992
12. El Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF. An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 1997a; 158: 2284-2290
13. El Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997b; 158: 1391-1394
14. Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, Kadowitz PJ, Hellstrom WJ. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol 2000; 163: 1992-1998
15. Hirano T. Interleukin-6. In: Thomson AW, editor: The cytokine handbook. London: Academic Press, 1991: 169-190
16. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleuking-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242 (2): 237-239
17. Manogue KR, van Deventer SJH, Cerami A. Tumour necrosis factor alpha or cachectin. In: Thomson AW, editor: The cytokine handbook. London: Academic Press, 1991: 241-256
18. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 576-606
19. Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: Relevance of angiogenetic factors. Anti-cancer Res 1999; 19: 1537-1540
20. Ahuja SK, Sikka SC, Hellstrom WJ. Stimulation of collagen production in an in vitro model for Peyronie's disease. Int J Impot Res 1999; 11: 207-212
21. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferon-alpha, -beta and -gamma. Scand J Urol Nephrol 1991; 25: 89-94
22. Judge IS, Wisniewski ZS. Intralesional interferon in the treatment of Peyronie's disease: a pilot study. Br J Urol 1997; 79: 40-42
23. Wegner HE, Andresen R, Knipsel HH, Miller K. Treatment of Peyronie's disease with local interferon-alpha 2b. Eur Urol 1995; 28: 236-240